<DOC>
	<DOC>NCT00372398</DOC>
	<brief_summary>The purpose of this trial is to study the proportion of scleroderma patients who suffer from asymptomatic coronary atherosclerosis compared to healthy controls.</brief_summary>
	<brief_title>Premature Coronary Atherosclerosis in Scleroderma</brief_title>
	<detailed_description>Coronary calcium scores will be obtained from a group of patients with scleroderma and a group of controls. Comparison of the calcium scores will be made.</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Scleroderma, Systemic</mesh_term>
	<mesh_term>Scleroderma, Diffuse</mesh_term>
	<mesh_term>Scleroderma, Localized</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>1. Age &gt;= 18 years. 2. Fulfillment of the American College of Rheumatology (ACR) criteria for the classification of scleroderma.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>scleroderma</keyword>
	<keyword>sclerosis</keyword>
	<keyword>atherosclerosis</keyword>
</DOC>